<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02389140</url>
  </required_header>
  <id_info>
    <org_study_id>14-1582</org_study_id>
    <secondary_id>UL1TR001082</secondary_id>
    <nct_id>NCT02389140</nct_id>
  </id_info>
  <brief_title>Blood Flow Within Active Myofascial Trigger Points Following Massage</brief_title>
  <official_title>Blood Flow Within Active Myofascial Trigger Points Following Massage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The physiological response at the myofascial trigger point (MTrP) to massage is not known,&#xD;
      yet would provide important objective evidence for a treatment effect and clarify the&#xD;
      resolution process of a MTrP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The physiological response at the myofascial trigger point (MTrP) to massage is not known,&#xD;
      yet would provide important objective evidence for a treatment effect and clarify the&#xD;
      resolution process of a MTrP. The long-term goal is to understand how therapeutic&#xD;
      intervention affects the physiology of the MTrP. The objective of the proposed research is to&#xD;
      assess, in a placebo controlled trial, the effectiveness of trigger point release massage&#xD;
      (also known as ischemic compression) on blood flow at an active MTrP. The central hypothesis&#xD;
      is that the contraction nodule of an active MTrP is characterized by an ischemic state&#xD;
      comprised of reduced blood flow and subsequent dysregulation in carbohydrate metabolism. The&#xD;
      investigators hypothesize that trigger point release (TPR) can positively impact blood flow&#xD;
      leading to a change in high energy carbohydrate tension. The present study has been&#xD;
      formulated, in part, from a preliminary study conducted by the investigators, which supports&#xD;
      reduced blood flow and physiological disruption at active MTrPs. The proposed research will&#xD;
      provide a physiological basis for massage to corroborate subjective reports of reduced pain&#xD;
      sensitivity, impart credibility to treatment techniques, and provide insight into a mechanism&#xD;
      of action for healing the MTrP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Blood Flow as measured by microdialysis</measure>
    <time_frame>1 hr pre intervention and 1 hr post intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Glucose as measured by microdialysis</measure>
    <time_frame>1 hr pre intervention and 1 hr post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lactate as measured by microdialysis</measure>
    <time_frame>1 hr pre intervention and 1 hr post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pyruvate as measured by microdialysis</measure>
    <time_frame>1 hr pre intervention and 1 hr post intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Myofascial Pain</condition>
  <condition>Tension-type Headache</condition>
  <arm_group>
    <arm_group_label>Trigger point treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Trigger point release</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham US at Trigger point</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Trigger point release</intervention_name>
    <description>Trigger point therapy</description>
    <arm_group_label>Trigger point treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>sham ultrasound</description>
    <arm_group_label>Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic or episodic tension-type headache&#xD;
&#xD;
          -  active MTrP in upper trapezius&#xD;
&#xD;
          -  age 21-49&#xD;
&#xD;
          -  BMI between 18.5-24.9&#xD;
&#xD;
          -  either gender&#xD;
&#xD;
          -  any race or ethnicity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No or latent MTrP in the upper trapezius&#xD;
&#xD;
          -  migraine 4+/month&#xD;
&#xD;
          -  cluster headache&#xD;
&#xD;
          -  fibromyalgia&#xD;
&#xD;
          -  neurological disease (e.g. Alzheimer's disease, Parkinson's disease, muscular&#xD;
             dystrophy, multiple sclerosis)&#xD;
&#xD;
          -  cardiovascular disease (e.g. prior heart attack or stroke)&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  a bleeding disorder (Self-report of hemophilia, known lack/deficiency of clotting&#xD;
             factors, or presently Â°taking anti-coagulants (e.g. warfarin, Coumadin))&#xD;
&#xD;
          -  narcotic use&#xD;
&#xD;
          -  currently receiving massage&#xD;
&#xD;
          -  prior trigger point injection or needling therapies&#xD;
&#xD;
          -  allergy to lidocaine-type anesthetics such as lidocaine and prilocaine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert Moraska, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>March 2, 2015</study_first_submitted>
  <study_first_submitted_qc>March 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2015</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood flow</keyword>
  <keyword>Glucose</keyword>
  <keyword>lactic acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tension-Type Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

